000 | 01814cam a2200517 i 4500 | ||
---|---|---|---|
001 | 20499171 | ||
003 | OSt | ||
005 | 20240423154837.0 | ||
008 | 180516t20172017enka b 001 0 eng c | ||
010 | _a 2017471123 | ||
016 | 7 |
_a101713541 _2DNLM |
|
020 | _a9781782627326 | ||
020 | _a1782627324 | ||
020 | _z9781788011532 (PDF) | ||
020 | _z9781788011716 (ePub) | ||
035 | _a(OCoLC)ocn974673515 | ||
040 |
_aNLM _beng _cNLM _erda _dBDX _dYDX _dCDX _dOCLCF _dBTCTA _dOCLCO _dOCLCA _dDLC |
||
042 | _apcc | ||
050 | 0 | 0 |
_aRM 301.25 .P378 2017 _b2024-7071 |
060 | 0 | 0 | _a2017 H-084 |
060 | 1 | 0 | _aQU 68 |
082 | 0 | 0 |
_a _2 |
245 | 0 | 0 |
_aPeptide-based drug discovery : _bchallenges and new therapeutics / _cedited by Ved Srivastava |
264 | 1 |
_aLondon : _bRoyal Society of Chemistry, _c[2017] |
|
300 |
_axxvii, 560 pages : _billustrations (some color) ; _c25 cm. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_aunmediated _bn _2rdamedia |
||
338 |
_avolume _bnc _2rdacarrier |
||
490 | 1 |
_aDrug discovery series, _x2041-3203 ; _v59 |
|
504 | _aIncludes bibliographical references and index. | ||
650 | 0 | _aDrug development. | |
650 | 0 | _aPeptide drugs. | |
650 | 0 |
_aDrugs _xDesign. |
|
650 | 1 | 2 |
_aPeptides _xpharmacokinetics. |
650 | 1 | 2 |
_aPeptides _xtherapeutic use. |
650 | 2 | 2 | _aDrug Discovery. |
650 | 7 |
_aDrug development. _2fast _0(OCoLC)fst00898670 |
|
650 | 7 |
_aDrugs _xDesign. _2fast _0(OCoLC)fst00898790 |
|
650 | 7 |
_aPeptide drugs. _2fast _0(OCoLC)fst01057556 |
|
700 | 1 |
_aSrivastava, Ved, _eeditor. |
|
710 | 2 |
_aRoyal Society of Chemistry (Great Britain), _epublisher. |
|
830 | 0 |
_aRSC drug discovery series ; _v59. _x2041-3203 |
|
906 |
_a7 _bcbc _cpccadap _d2 _encip _f20 _gy-gencatlg |
||
942 |
_2lcc _cBK _n0 |
||
999 |
_c491 _d491 |